Skip to content

NGNE

Neurogene Inc.

NASDAQ · USHealthcareBiotechnology
$37.34+0.08%

Price as of Jul 20, 2026

NGNE capital

Neurogene Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.04x
Net debt / equity
-0.48x
Debt / assets
0.03x
Debt / EBITDA
-0.10x
Net debt / EBITDA
1.21x

Liquidity & coverage

Current ratio
13.08x
Quick ratio
13.08x
Cash ratio
12.89x
Interest coverage
EBITDA / interest
Working capital
$227.9M

Cash & dividend

FCF / debt
-9.05x
Cash flow / debt
-8.97x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.